Ireland’s CBD Sector in 2025: Facing Unprecedented Regulatory Pressure

In 2025, Ireland’s retailers, importers, and manufacturers face the tightest cannabis compliance regime yet in the EU. The Food Safety Authority of Ireland (FSAI), in alignment with the European Food Safety Authority (EFSA), is enforcing the EU Novel Foods Regulation with increasing rigor. This means that all foods, beverages, and food supplements containing cannabidiol (CBD) are now heavily scrutinized. The headline? No CBD edible or drink is permitted on the Irish or EU market unless it receives formal novel food authorization—a hurdle that, as of September 2025, has not been cleared by a single CBD ingestible.

The result is a regulatory landscape defined by product withdrawals, spot-checks, and enforcement blitzes. For anyone operating in Ireland’s cannabis or CBD industry, immediate adaptation is critical.

The Legal Status of CBD in Ireland

CBD is not regarded as a narcotic drug in Ireland and is not a controlled substance under the Misuse of Drugs Act 1977. However, how CBD is sold, labeled, and formulated for the consumer market puts virtually all ingestible products under the purview of the EU Novel Foods Regulation (EU) 2015/2283.

FSAI maintains a zero-tolerance approach: no CBD supplements or foods are authorized for sale unless they appear on the EU’s official list of novel foods, which is managed at the Union level. As of September 2025, there have been no approvals.

What This Means for Retailers and Online Stores

• CBD oils, drinks, gummies, supplements, and most edibles are unlawful unless authorized.
• Any ingestible CBD product present on shelves can trigger enforcement action, including mandatory product withdrawal and investigation.
• Topical cosmetics, vapes, and hemp seed foods (without CBD extracts or added cannabinoids) have a different pathway and are not under novel foods, but are still subject to other sector-specific rules.

Further reading: FSAI: Regulation of CBD and Hemp Food Products in Ireland

FSAI Enforcement: 2025 Actions and Signals

Since late 2024 into 2025, FSAI has ordered multiple high-profile withdrawals of CBD supplements, beverages, and oils from the Irish market, often triggering supply chain recalls. Key trends in enforcement include:

• Spot-checking retail and online outlets for unauthorized ingestibles.
• Product testing for undeclared CBD/THC and prohibited contaminants.
• Scrutiny of product claims—no unauthorized health claims are tolerated and nutritional statements must comply with Regulation (EC) No. 1924/2006.
• Action targeting non-Irish online sellers who fail to restrict access to Irish addresses. Geofencing and SKU-specific restrictions are expected as best practice.
• Borderline cases: Products marketed as both supplement and food (such as tinctures or drops), or as quasi-medical items, are likely targets for investigation and require robust compliance dossiers.

Cited: FSAI Food Alerts and Recalls

Navigating Novel Foods: What Makes a Valid CBD Product in Ireland?

What Is a "Novel Food"?

A novel food is any food not consumed to a significant degree in the EU before May 15, 1997. CBD extracts and isolates, unless derived using traditional cold-pressing methods from hemp seeds/fibers (which is rare), are considered novel.

The Authorisation Process for CBD

• Dossier Submission: Applicants must demonstrate product safety, toxicology, manufacturing details, and purity.
• Scientific Review: The European Commission and EFSA conduct a rigorous risk assessment, now even stricter after the 2025 EFSA guidance update.
• Union List Addition: Only when approved does the product join the official Union List for legal sale.

As of September 2025, no CBD edible, supplement, or beverage has been authorized at the EU or Member State level. All retail CBD foods in Ireland are technically non-compliant.

Further Reading: EU 2025: EFSA’s Tougher Novel Food Dossier Rules Put CBD Back to Square One

Mandatory Compliance Checklist: Survival Steps for Retailers

1. Remove Unauthorized CBD Foods and Beverages

Immediately audit all CBD edibles, oils, drinks, and supplements against the EU’s Union List of authorized novel foods. Remove anything not explicitly authorized. Even carrying loss-leader CBD snacks or drinks risks enforcement.

2. Label Audit & Certificate of Analysis (CoA) Review

• Verify THC compliance (should be non-detectable or below the 0.2% threshold, but FSAI may require true-zero for ingestibles).
• Check CBD content vs. label—mislabeled content triggers recalls.
• Scan CoAs for pesticides, heavy metals, or residual solvents (FSAI will test for contaminants).

3. Segregate and Reclassify Topicals and Cosmetics

• CBD-containing skincare, balms, and cosmetics should be clearly separated, and must follow cosmetics legislation.
• No oral/topical dual-use or marketing blurring.

4. Geofence Online Stores and Exclude Ireland for Non-Compliant SKUs

• If serving Irish customers online, configure your e-commerce platform to block the sale of non-compliant items.
• Clearly state Ireland’s restrictions on product listings.

5. Plan Dossiers for Borderline Products

• Tinctures, drops, novel format supplements: map out the evidentiary and risk assessment requirements for eventual EU novel food authorization.
• Prepare a compliance and pharmacovigilance system to log and respond to adverse event reports.

6. Claims and Marketing Discipline

• Never make therapeutic, medical, or unauthorized nutritional claims for any CBD product.
• Use only approved health claims for food supplements, as listed in EU Register of Nutrition and Health Claims.

Penalties and Enforcement Patterns

Failure to comply can result in:

• Immediate withdrawal and destruction of non-compliant products.
• Public recall notifications on FSAI channels.
• Potential administrative fines and reputational damage.
• Repeat or egregious violations may prompt criminal investigation.

There is no grandfathering or grace period for existing stock. The FSAI’s approach is proactive, not reactive—retailers should not wait for a warning.

Key Takeaways for the Irish CBD Market in 2025

• CBD is legal only outside foods and ingestibles unless EU-authorized as a novel food.
• The FSAI is actively policing the market, with online and offline spot-checks and coordination with customs.
• Retailers, importers, and online sellers must rigorously audit and adapt portfolios—elimination of non-authorized SKUs is urgent.
• Submission for EU Novel Food authorization is possible, but successful approval is a multi-year, evidentiary process.

Resources and Support

• Food Safety Authority of Ireland: CBD Business Guidance
• FSAI Food Supplements Labelling and Claims Rules
• Health Products Regulatory Authority: Cosmetics Guidelines
• EU Register of Nutrition and Health Claims

For real-time updates, tailored compliance solutions, and expert support, rely on CannabisRegulations.ai—your partner for navigating Ireland’s CBD novel foods landscape in 2025 and beyond.